HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Analysis of a shared pancreatic cancer antigen recognized by an HLA-A*2601-restricted cytotoxic T-lymphocyte clone.

AbstractINTRODUCTION:
We have generated HLA-A*2601-restricted CD8+ CTL clones against an autologous pancreatic cancer cell line.
AIMS:
To characterize the antigen expressed on the cancer cells.
METHODOLOGY:
We assessed cytotoxic activities and cytokine production of these CTL clones reacting against cancer cell lines that stably or transiently expressed the HLA-A*2601 gene.
RESULTS:
These CTL clones recognized 4 of 10 allogeneic pancreatic cancer cell lines and a gallbladder cancer cell line in the context of HLA-A*2601. However, the CTL clones did not recognize three hepatocellular carcinoma cell lines, two esophageal squamous cell carcinoma cell lines, or a lung adenocarcinoma cell line.
CONCLUSIONS:
Thus, the CTL clones may recognize a shared, but not ubiquitously expressed, tumor antigen on pancreatic and gallbladder cancer cells.
AuthorsKiyoteru Kashiwagi, Hideyuki Ikeda, Yoshihiko Hirohashi, Masayuki Yamamoto, Satomi Idenoue, Itaru Hirai, Kenjiro Kamiguchi, Yasuaki Tamura, Toshiko Torigoe, Yshimasa Wada, Koichi Hirata, Noriyuki Sato
JournalPancreas (Pancreas) Vol. 26 Issue 4 Pg. e81-8 (May 2003) ISSN: 1536-4828 [Electronic] United States
PMID12717278 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Neoplasm
  • HLA-A Antigens
  • HLA-A*26 antigen
  • Granulocyte-Macrophage Colony-Stimulating Factor
Topics
  • Antigens, Neoplasm (analysis, immunology)
  • Cell Line, Tumor
  • Cytotoxicity Tests, Immunologic
  • Cytotoxicity, Immunologic (immunology)
  • Genotype
  • Granulocyte-Macrophage Colony-Stimulating Factor (biosynthesis)
  • HLA-A Antigens (genetics, immunology)
  • Humans
  • K562 Cells
  • Pancreatic Neoplasms (genetics, immunology, metabolism)
  • T-Lymphocytes, Cytotoxic (cytology, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: